T H E K O R E A N D O C T O R S W E E K L Y www.docdocdoc.co.kr I N S I D E 38 3 5 6 7 10 13 28 29 30 31 38 41 42
2 Advertisement
Government & Medicine 3 Government & Medicine
4 Government & Medicine
Government & Medicine 5
6 Government & Medicine
Government & Medicine 7
8 Advertisement
Government & Medicine 9
10 Government & Medicine
Advertisement 11
12 Advertisement
Government & Medicine 13 @nho kyungwoo @SYK @Kwon,HyeokJae @ @ @Kwon,HyeokJae @ @ @XrayOh @XrayOh
14 Advertisement
Government & Medicine 15
16 Cover Stories
Cover Stories 17 interview
18 Health & Science Health & Science OBJECTIVE: To investigate the impact of glycemic control on the survival of diabetic subjects with end-stage renal disease (ESRD) starting hemodialysis treatment. RESEARCH DESIGN AND METHODS: This single-center prospective observational study enrolled 150 diabetic ESRD subjects (109 men and 41 women; age at hemodialysis initiation, 60.5 +/- 10.2 years) at start of hemodialysis between January 1989 and December 1997. The subjects were divided into groups according to their glycemic control level at inclusion as follows: good HbA1c <7.5%, n = 93 (group G), and poor HbA1c > or = 7.5%, n = 57 (group P); and survival was followed until December 1999, with a mean follow-up period of 2.7 years. RESULTS: Group G had better survival than group P (the control group) (P = 0.008). At inclusion, there was no significant difference in age, sex, systolic blood pressure (SBP), BMI, cardio-to-thoracic ratio (CTR) on chest X-ray, and serum creatinine (Cre) or hemoglobin (Hb) levels between the two groups. After adjustment for age and sex, HbA1c was a significant predictor of survival (hazard ratio 1. 133 per 1.0% increment of HbA1c, 95% CI 1.028-1.249, P = 0.012), as were Cre and CTR. CONCLUSIONS: Good glycemic control (HbA1c <7.5%) predicts better survival of diabetic ESRD patients starting hemodialysis treatment.
Advertisement 19
20 Advertisement
Health & Science 21
22 Health & Science
Health & Science 23 Discussion
24 Health & Science Discussion
Health & Science 25 Discussion
26 Health & Science
Advertisement 27
28 Specialties Specialties
Specialties 29
30 Specialties
Specialties 31
32 Specialties
Advertisement 2 0 1 1 1 1 0 7 33
34 Business Business
Business 35
36 Advertisement
Business 37
38 doctor s view Doctor s View
Advertisement 39
40 Advertisement
Doctor s View 41
42 Doctor s View
Advertisement 43
THE KOREAN DOCTORS WEEKLY Monday, November 7, 2011